Literature DB >> 23509136

Tramadol.

James W S Young1, David N Juurlink.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23509136      PMCID： PMC3652964          DOI： 10.1503/cmaj.121592

Source DB:  PubMed          Journal:  CMAJ        ISSN： 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  6 in total

Review 1.  CYP2D6 in the metabolism of opioids for mild to moderate pain.

Authors:  Wojciech Leppert
Journal:  Pharmacology       Date:  2011-04-15       Impact factor: 2.547

2.  Tramadol-induced apnea.

Authors:  Hossein Hassanian-Moghaddam; Hoorvash Farajidana; Saeedeh Sarjami; Hamid Owliaey
Journal:  Am J Emerg Med       Date:  2012-07-16       Impact factor: 2.469

3.  Canadian guideline for safe and effective use of opioids for chronic noncancer pain: clinical summary for family physicians. Part 1: general population.

Authors:  Meldon Kahan; Angela Mailis-Gagnon; Lynn Wilson; Anita Srivastava
Journal:  Can Fam Physician       Date:  2011-11       Impact factor: 3.275

Review 4.  Tramadol for neuropathic pain.

Authors:  J Hollingshead; R M Dühmke; D R Cornblath
Journal:  Cochrane Database Syst Rev       Date:  2006-07-19

Review 5.  Tramadol for osteoarthritis.

Authors:  M S Cepeda; F Camargo; C Zea; L Valencia
Journal:  Cochrane Database Syst Rev       Date:  2006-07-19

6.  Physical dependence on Ultram (tramadol hydrochloride): both opioid-like and atypical withdrawal symptoms occur.

Authors:  Edward C Senay; Edgar H Adams; Anne Geller; James A Inciardi; Alvaro Muñoz; Sidney H Schnoll; George E Woody; Theodore J Cicero
Journal:  Drug Alcohol Depend       Date:  2003-04-01       Impact factor: 4.492
  6 in total
  5 in total

1.  Prevalence and characteristics of hospitalized adults on chronic opioid therapy.

Authors:  Hilary J Mosher; Lan Jiang; Mary S Vaughan Sarrazin; Peter Cram; Peter J Kaboli; Mark W Vander Weg
Journal:  J Hosp Med       Date:  2013-12-06       Impact factor: 2.960

2.  Trends in prevalent and incident opioid receipt: an observational study in Veterans Health Administration 2004-2012.

Authors:  H J Mosher; E E Krebs; M Carrel; P J Kaboli; M W Vander Weg; B C Lund
Journal:  J Gen Intern Med       Date:  2014-12-18       Impact factor: 5.128

3.  LC-MS/MS Quantification of Tramadol and Gabapentin Utilizing Solid Phase Extraction.

Authors:  Pappula Nagaraju; Balaji Kodali; Peda Varma Datla; Surya Prakasarao Kovvasu
Journal:  Int J Anal Chem       Date:  2018-10-28       Impact factor: 1.885

4.  Opioid Prescribing After Surgery in the United States, Canada, and Sweden.

Authors:  Karim S Ladha; Mark D Neuman; Gabriella Broms; Jennifer Bethell; Brian T Bateman; Duminda N Wijeysundera; Max Bell; Linn Hallqvist; Tobias Svensson; Craig W Newcomb; Colleen M Brensinger; Lakisha J Gaskins; Hannah Wunsch
Journal:  JAMA Netw Open       Date:  2019-09-04

5.  Opioid Use at End-Of-Life Among Nova Scotia Patients With Cancer.

Authors:  Laura V Minard; Judith Fisher; Larry Broadfield; Gordon Walsh; Ingrid Sketris
Journal:  Front Pharmacol       Date:  2022-03-24       Impact factor: 5.810
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.